Novartis names new heads for Alcon and Sandoz divisions
ZURICH, April 9
ZURICH, April 9 (Reuters) - Swiss drugmaker Novartis has appointed new heads of its eyecare business Alcon and generics division Sandoz, the group's second and third largest businesses after pharmaceuticals.
Jeff George, who previously led Sandoz, will replace retiring Kevin Buehler as head of Alcon, effective May 1, Novartis said on Wednesday.
Richard Francis will become head of Sandoz, the drugmaker added. Francis previously held leadership roles in sales and commercial divisions at Sanofi and Wyeth.
Alcon and Sandoz generated net sales of $10.5 billion and $9.2 billion in 2013, respectively. (Reporting by Alice Baghdjian; Editing by Mark Potter)